en-usThere continue to be uncertainties about the optimal diagnosis and management of many kidney diseases. The goal of this series is to provide readers with an overview on these areas of uncertainty. Each debate series will consist of PRO and CON arguments written by two experts on the subject matter. In addition, a moderator will summarize the two sides of the debate, and provide a balanced perspective on the ongoing controversies.<p></p>Fri, 19 Apr 2024 10:27:08 GMThttp://cct.highwire.org/feeds/asn/debates-in-nephrology.rss10.34067/KID.0000742022Mon, 28 Feb 2022 06:11:13 GMT-08:00Screening for Cardiovascular Disease in CKD: COMMENTARYMcCallum, WendySarnak, Mark J.2022-02-28T18:11:13-08:00doi:10.34067/KID.0000742022hwp:resource-id:kidney360;3/11/1839American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360chronic kidney disease, coronary disease, screeningModerator CommentaryModerator Commentaryarticle-commentary20222022-11-2410.34067/KID.00007420222641-76502022-02-28T18:11:13-08:002022-11-24Kidney360Moderator Commentary3111839184110.34067/KID.0005012021Mon, 28 Feb 2022 06:11:13 GMT-08:00Screening for Cardiovascular Disease in CKD: PROJain, NishankMcAdams, MeredithHedayati, S. Susan2022-02-28T18:11:13-08:00doi:10.34067/KID.0005012021hwp:resource-id:kidney360;3/11/1831American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360chronic kidney disease, cardiac biomarkers, cardiac imaging, cardiovascular disease, screeningDebates in NephrologyDebates in Nephrologyresearch-article20222022-11-2410.34067/KID.00050120212641-76502022-02-28T18:11:13-08:002022-11-24Kidney360Debates in Nephrology3111831183510.34067/KID.0004742021Mon, 28 Feb 2022 06:11:13 GMT-08:00Screening for Cardiovascular Disease in CKD: CONRamos, Giana K.Charytan, David M2022-02-28T18:11:13-08:00doi:10.34067/KID.0004742021hwp:resource-id:kidney360;3/11/1836American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360clinical nephrology, CKD, coronary artery disease, stress testDebates in NephrologyDebates in Nephrologyresearch-article20222022-11-2410.34067/KID.00047420212641-76502022-02-28T18:11:13-08:002022-11-24Kidney360Debates in Nephrology3111836183810.34067/KID.0007762021Tue, 15 Feb 2022 09:28:57 GMT-08:00Kidney Biopsy Should Remain a Required Procedure for Nephrology Training Programs: CONRodby, Roger A.2022-02-15T09:28:57-08:00doi:10.34067/KID.0007762021hwp:resource-id:kidney360;3/10/1667American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360clinical nephrology, ABIM requirements, ACGME requirements, nephrology fellowship, percutaneous renal biopsyDebates in NephrologyDebates in Nephrologyarticle-commentary20222022-10-2710.34067/KID.00077620212641-76502022-02-15T09:28:57-08:002022-10-27Kidney360Debates in Nephrology3101667166910.34067/KID.0007772021Tue, 15 Feb 2022 09:28:57 GMT-08:00Kidney Biopsy Should Remain a Required Procedure for Nephrology Training Programs: PROObaidi, ZainabSozio, Stephen M.2022-02-15T09:28:57-08:00doi:10.34067/KID.0007772021hwp:resource-id:kidney360;3/10/1664American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360clinical nephrology, biopsy, fellowship, nephrologyDebates in NephrologyDebates in Nephrologyarticle-commentary20222022-10-2710.34067/KID.00077720212641-76502022-02-15T09:28:57-08:002022-10-27Kidney360Debates in Nephrology3101664166610.34067/KID.0000872022Tue, 15 Feb 2022 09:28:57 GMT-08:00Kidney Biopsy Should Remain a Required Procedure for Nephrology Training Programs: COMMENTARYBrewster, Ursula C.2022-02-15T09:28:57-08:00doi:10.34067/KID.0000872022hwp:resource-id:kidney360;3/10/1670American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360clinical nephrology, biopsy, nephrologyModerator CommentaryModerator Commentaryarticle-commentary20222022-10-2710.34067/KID.00008720222641-76502022-02-15T09:28:57-08:002022-10-27Kidney360Moderator Commentary3101670167110.34067/KID.0008112021Wed, 26 Jan 2022 01:33:56 GMT-08:00Vancomycin Should Be Considered a Nephrotoxic Antimicrobial Agent: COMMENTARYPerazella, Mark A.2022-01-26T13:33:56-08:00doi:10.34067/KID.0008112021hwp:resource-id:kidney360;3/9/1491American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360nephro-pharmacology, acute interstitial nephritis, acute kidney injury, acute tubular injury, cast nephropathy, nephrotoxicity, vancomycinModerator CommentaryModerator Commentaryarticle-commentary20222022-09-2910.34067/KID.00081120212641-76502022-01-26T13:33:56-08:002022-09-29Kidney360Moderator Commentary391491149310.34067/KID.0008032021Wed, 26 Jan 2022 01:33:56 GMT-08:00Vancomycin Should Be Considered a Nephrotoxic Antimicrobial Agent: PROMurphy, Mark E.Barreto, Erin F.2022-01-26T13:33:56-08:00doi:10.34067/KID.0008032021hwp:resource-id:kidney360;3/9/1484American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360acute kidney injury and ICU nephrology, acute kidney injury, adverse drug reaction, antibiotic, pharmacokinetic/pharmacodynamics, renal failure, toxicity, vancomycinDebates in NephrologyDebates in Nephrologyresearch-article20222022-09-2910.34067/KID.00080320212641-76502022-01-26T13:33:56-08:002022-09-29Kidney360Debates in Nephrology391484148710.34067/KID.0007932021Wed, 26 Jan 2022 01:33:56 GMT-08:00Vancomycin Should Be Considered a Nephrotoxic Antimicrobial Agent: CONMullaney, Scott R.2022-01-26T13:33:56-08:00doi:10.34067/KID.0007932021hwp:resource-id:kidney360;3/9/1488American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360nephro-pharmacology, acute kidney injury, AKI, anti-infective agents, vancomycinDebates in NephrologyDebates in Nephrologyresearch-article20222022-09-2910.34067/KID.00079320212641-76502022-01-26T13:33:56-08:002022-09-29Kidney360Debates in Nephrology3914881490This is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0002492022 and the CON: 10.34067/KID.0002512022rbrown@bidmc.harvard.edu10.34067/KID.0002502022Tue, 20 Sep 2022 11:25:45 GMT-07:00Fractional Excretion of Sodium and Urea are Useful Tools in the Evaluation of AKI: COMMENTARYThis is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0002492022 and the CON: 10.34067/KID.0002512022Brown, Robert S.2022-09-20T11:25:45-07:00doi:10.34067/KID.0002502022hwp:resource-id:kidney360;KID.0002502022v1American Society of NephrologyCopyright © 2022 American Society of NephrologyKidney360FENa, FEUrea, Fractional excretion, Acute kidney injury, AKI, Prerenal, ATN, SodiumModerator CommentaryModerator Commentaryother202210.34067/KID.00025020222641-76502641-76502022-09-20T11:25:45-07:00Kidney360Moderator Commentary10.34067/KID.0002502022This is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0002492022 and the COMMENTARY: 10.34067/KID.0002502022awaron@stanford.edu10.34067/KID.0002512022Tue, 20 Sep 2022 11:25:45 GMT-07:00Fractional Excretion of Sodium and Urea are Useful Tools in the Evaluation of AKI: CONThis is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0002492022 and the COMMENTARY: 10.34067/KID.0002502022Aron, Abraham WAmatruda, Jonathan G2022-09-20T11:25:45-07:00doi:10.34067/KID.0002512022hwp:resource-id:kidney360;KID.0002512022v1American Society of NephrologyCopyright © 2022 American Society of NephrologyKidney360Urine electrolytes, FENa, FEUrea, AKIDebates in NephrologyDebates in Nephrologyother202210.34067/KID.00025120222641-76502641-76502022-09-20T11:25:45-07:00Kidney360Debates in Nephrology10.34067/KID.0002512022This is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the CON: 10.34067/KID.0002512022 and the COMMENTARY: 10.34067/KID.0002502022.kamelgharaibeh@gmail.com10.34067/KID.0002492022Tue, 20 Sep 2022 11:25:45 GMT-07:00Fractional Excretion of Sodium and Urea are Useful Tools in the Evaluation of AKI: PROThis is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the CON: 10.34067/KID.0002512022 and the COMMENTARY: 10.34067/KID.0002502022.Hamadah, AbdurrahmanGharaibeh, Kamel2022-09-20T11:25:45-07:00doi:10.34067/KID.0002492022hwp:resource-id:kidney360;KID.0002492022v1American Society of NephrologyCopyright © 2022 American Society of NephrologyKidney360Acute Kidney Injury, Urea, SodiumDebates in NephrologyDebates in Nephrologyother202210.34067/KID.00024920222641-76502641-76502022-09-20T11:25:45-07:00Kidney360Debates in Nephrology10.34067/KID.0002492022andrew.donati@yale.edu10.34067/KID.0006642021Thu, 20 Jan 2022 12:28:46 GMT-08:00Should Corticosteroids Be Used to Treat Biopsy-Proven Drug-Induced Acute Interstitial Nephritis?: PRODonati, AndrewKrishnan, Namrata2022-01-20T12:28:46-08:00doi:10.34067/KID.0006642021hwp:resource-id:kidney360;3/8/1306American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360clinical nephrology, acute interstitial nephritis, acute kidney injury, biopsy, drug-induced acute interstitial nephritis, glucocorticoids, steroidsDebates in NephrologyDebates in Nephrologyresearch-article20222022-08-2510.34067/KID.00066420212641-76502022-01-20T12:28:46-08:002022-08-25Kidney360Debates in Nephrology381306130910.34067/KID.0007042021Thu, 20 Jan 2022 12:28:46 GMT-08:00Should Corticosteroids Be Used to Treat Biopsy-Proven Drug-Induced Acute Interstitial Nephritis?: CONGallagher, Martin P.Kotwal, Sradha2022-01-20T12:28:46-08:00doi:10.34067/KID.0007042021hwp:resource-id:kidney360;3/8/1310American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360nephro-pharmacology, acute interstitial nephritis, biopsy, corticosteroidsDebates in NephrologyDebates in Nephrologyresearch-article20222022-08-2510.34067/KID.00070420212641-76502022-01-20T12:28:46-08:002022-08-25Kidney360Debates in Nephrology381310131310.34067/KID.0008342021Thu, 20 Jan 2022 12:28:46 GMT-08:00Should Corticosteroids be Used To Treat Biopsy-Proven Drug-Induced Acute Interstitial Nephritis?: COMMENTARYPraga, ManuelCaravaca-Fontán, Fernando2022-01-20T12:28:46-08:00doi:10.34067/KID.0008342021hwp:resource-id:kidney360;3/8/1314American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360clinical nephrology, acute interstitial nephritis, biopsy, corticosteroidsModerator CommentaryModerator Commentaryarticle-commentary20222022-08-2510.34067/KID.00083420212641-76502022-01-20T12:28:46-08:002022-08-25Kidney360Moderator Commentary381314131610.34067/KID.0007622021Tue, 04 Jan 2022 05:02:17 GMT-08:00Do Proton-Pump Inhibitors Cause CKD and Progression of CKD?: PROAwdishu, LindaAbagyan, Ruben2022-01-04T17:02:17-08:00doi:10.34067/KID.0007622021hwp:resource-id:kidney360;3/7/1134American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360nephro-pharmacology, chronic kidney disease, chronic kidney disease progression, nephrotoxicity, proton-pump inhibitorsDebates in NephrologyDebates in Nephrologyresearch-article20222022-07-2810.34067/KID.00076220212641-76502022-01-04T17:02:17-08:002022-07-28Kidney360Debates in Nephrology371134113610.34067/KID.0008302021Tue, 04 Jan 2022 05:02:17 GMT-08:00Do Proton-Pump Inhibitors Cause CKD and Progression of CKD?: COMMENTARYPaueksakon, PaisitFogo, Agnes B.2022-01-04T17:02:17-08:00doi:10.34067/KID.0008302021hwp:resource-id:kidney360;3/7/1141American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360chronic kidney disease, acute tubulointerstitial nephritis, proton-pump inhibitorsModerator CommentaryModerator Commentaryarticle-commentary20222022-07-2810.34067/KID.00083020212641-76502022-01-04T17:02:17-08:002022-07-28Kidney360Moderator Commentary371141114310.34067/KID.0005852021Tue, 04 Jan 2022 05:02:17 GMT-08:00Do Proton-Pump Inhibitors Cause CKD and Progression of CKD?: CONCholin, LizaNakhoul, Georges2022-01-04T17:02:17-08:00doi:10.34067/KID.0005852021hwp:resource-id:kidney360;3/7/1137American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360chronic kidney disease, nephropharmacology, proton-pump inhibitorsDebates in NephrologyDebates in Nephrologyresearch-article20222022-07-2810.34067/KID.00058520212641-76502022-01-04T17:02:17-08:002022-07-28Kidney360Debates in Nephrology371137114010.34067/KID.0002082021Fri, 15 Oct 2021 09:31:44 GMT-07:00Is Prioritization of Kidney Allografts to Combined Liver-Kidney Recipients Appropriate? CONCheng, Xingxing S.2021-10-15T09:31:44-07:00doi:10.34067/KID.0002082021hwp:resource-id:kidney360;3/6/996American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360transplantation, allografts, Kidney Allocation System, multiorgan transplants, organ transplantation, prioritization, simultaneous liver-kidneyDebates in NephrologyDebates in Nephrologyresearch-article20222022-06-3010.34067/KID.00020820212641-76502021-10-15T09:31:44-07:002022-06-30Kidney360Debates in Nephrology3699699810.34067/KID.0001632021Fri, 15 Oct 2021 09:31:44 GMT-07:00Is Prioritization of Kidney Allografts to Combined Liver-Kidney Recipients Appropriate? PROTruong, Tiffany T.Nadim, Mitra K.2021-10-15T09:31:44-07:00doi:10.34067/KID.0001632021hwp:resource-id:kidney360;3/6/993American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360transplantation, kidney dysfunction, kidney transplant, liver transplant, liver-kidney transplant, MELD, safety netDebates in NephrologyDebates in Nephrologyresearch-article20222022-06-3010.34067/KID.00016320212641-76502021-10-15T09:31:44-07:002022-06-30Kidney360Debates in Nephrology3699399510.34067/KID.0005042021Fri, 15 Oct 2021 09:31:44 GMT-07:00Is Prioritization of Kidney Allografts to Combined Liver-Kidney Recipients Appropriate? COMMENTARYAsch, William S.2021-10-15T09:31:44-07:00doi:10.34067/KID.0005042021hwp:resource-id:kidney360;3/6/999American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360transplantation, allocation, criteria, eligibility, Equity, OPTN, SLKT, UNOS, waitlistModerator CommentaryModerator Commentaryarticle-commentary20222022-06-3010.34067/KID.00050420212641-76502021-10-15T09:31:44-07:002022-06-30Kidney360Moderator Commentary369991002This is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0001422022 and the COMMENTARY: 10.34067/KID.0001452022rondonberriosh@upmc.edu10.34067/KID.0001412022Thu, 02 Jun 2022 10:04:41 GMT-07:00Cerebral salt wasting is a real cause of hyponatremia: CONThis is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0001422022 and the COMMENTARY: 10.34067/KID.0001452022Sterns, Richard H.Rondon-Berrios, Helbert2022-06-02T10:04:41-07:00doi:10.34067/KID.0001412022hwp:resource-id:kidney360;KID.0001412022v1American Society of NephrologyCopyright © 2022 American Society of NephrologyKidney360Hyponatremia, SIADH, Cerebral Salt WastingDebates in NephrologyDebates in Nephrologyother202210.34067/KID.00014120222641-76502641-76502022-06-02T10:04:41-07:00Kidney360Debates in Nephrology10.34067/KID.0001412022This is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the CON: 10.34067/KID.0001412022 and the COMMENTARY: 10.34067/KID.0001452022John.Maesaka@nyulangone.org10.34067/KID.0001422022Thu, 02 Jun 2022 10:04:41 GMT-07:00Cerebral salt wasting is a real cause of hyponatremia: PROThis is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the CON: 10.34067/KID.0001412022 and the COMMENTARY: 10.34067/KID.0001452022Maesaka, John K.Imbriano, Louis J.2022-06-02T10:04:41-07:00doi:10.34067/KID.0001422022hwp:resource-id:kidney360;KID.0001422022v1American Society of NephrologyCopyright © 2022 American Society of NephrologyKidney360cerebral salt wasting, HyponatremiaDebates in NephrologyDebates in Nephrologyother202210.34067/KID.00014220222641-76502641-76502022-06-02T10:04:41-07:00Kidney360Debates in Nephrology10.34067/KID.0001422022This is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0001422022 and the CON: 10.34067/KID.0001412022biff.palmer@utsouthwestern.edu10.34067/KID.0001452022Thu, 02 Jun 2022 10:04:41 GMT-07:00Cerebral salt wasting is a real cause of hyponatremia: CommentaryThis is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0001422022 and the CON: 10.34067/KID.0001412022Palmer, Biff F.Clegg, Deborah J.2022-06-02T10:04:41-07:00doi:10.34067/KID.0001452022hwp:resource-id:kidney360;KID.0001452022v1American Society of NephrologyCopyright © 2022 American Society of NephrologyKidney360hyponatremia, cerebral salt wasting, natriuretic peptides, brain natriuretic peptide, SIADH, vasopressin, syndrome of antidiuretic hormone secretionModerator CommentaryModerator Commentaryother202210.34067/KID.00014520222641-76502641-76502022-06-02T10:04:41-07:00Kidney360Moderator Commentary10.34067/KID.000145202210.34067/KID.0005592021Fri, 17 Sep 2021 11:21:16 GMT-07:00Is Rechallenge Appropriate in Patients that Develop Immune Checkpoint Inhibitor-Associated AKI?: COMMENTARYShirali, Anushree C.2021-09-17T11:21:16-07:00doi:10.34067/KID.0005592021hwp:resource-id:kidney360;3/5/806American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360acute kidney injury and ICU nephrology, acute kidney injury, drug toxicity, immune checkpoint inhibitors, immunotherapy, onco-nephrologyModerator CommentaryModerator Commentaryarticle-commentary20222022-05-2610.34067/KID.00055920212641-76502021-09-17T11:21:16-07:002022-05-26Kidney360Moderator Commentary3580680810.34067/KID.0003962021Fri, 17 Sep 2021 11:21:16 GMT-07:00Is Rechallenge Appropriate in Patients that Develop Immune Checkpoint Inhibitor-Associated AKI?: PROHerrmann, Sandra M.2021-09-17T11:21:16-07:00doi:10.34067/KID.0003962021hwp:resource-id:kidney360;3/5/799American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360acute kidney injury and ICU nephrology, acute kidney injury, debates, immune checkpoint inhibitor, rechallengeDebates in NephrologyDebates in Nephrologyresearch-article20222022-05-2610.34067/KID.00039620212641-76502021-09-17T11:21:16-07:002022-05-26Kidney360Debates in Nephrology3579980210.34067/KID.0003902021Fri, 17 Sep 2021 11:21:16 GMT-07:00Is Rechallenge Appropriate in Patients that Develop Immune Checkpoint Inhibitor-Associated AKI?: CONKanduri, Swetha RaniVelez, Juan Carlos Q.2021-09-17T11:21:16-07:00doi:10.34067/KID.0003902021hwp:resource-id:kidney360;3/5/803American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360acute kidney injury and ICU nephrology, acute interstitial nephritis, acute kidney injury, causality, CONS, debates, immune checkpoint inhibitors, immune-related adverse effects, rechallengeDebates in NephrologyDebates in Nephrologyarticle-commentary20222022-05-2610.34067/KID.00039020212641-76502021-09-17T11:21:16-07:002022-05-26Kidney360Debates in Nephrology35803805This is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0007432021 and the CON: 10.34067/KID.0007422021tichang@stanford.edu10.34067/KID.0007442021Wed, 11 May 2022 01:40:23 GMT-07:00Midodrine is an effective therapy for resistant intradialytic hypotension: COMMENTARYThis is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0007432021 and the CON: 10.34067/KID.0007422021Kim, Jackson P.Chang, Tara I.2022-05-11T13:40:23-07:00doi:10.34067/KID.0007442021hwp:resource-id:kidney360;KID.0007442021v1American Society of NephrologyCopyright © 2022 American Society of NephrologyKidney360Midodrine, intradialytic hypotension, Hemodynamics and Vascular Regulation, NephropharmacologyModerator CommentaryModerator Commentaryother202210.34067/KID.00074420212641-76502641-76502022-05-11T13:40:23-07:00Kidney360Moderator Commentary10.34067/KID.0007442021This is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the CON: 10.34067/KID.0007422021 and the COMMENTARY: 10.34067/KID.0007442021Andrew.House@lhsc.on.ca10.34067/KID.0007432021Wed, 11 May 2022 01:40:23 GMT-07:00Midodrine is an effective therapy for resistant intradialytic hypotension: PROThis is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the CON: 10.34067/KID.0007422021 and the COMMENTARY: 10.34067/KID.0007442021House, Andrew A.McIntyre, Christopher W.2022-05-11T13:40:23-07:00doi:10.34067/KID.0007432021hwp:resource-id:kidney360;KID.0007432021v1American Society of NephrologyCopyright © 2022 American Society of NephrologyKidney360midodrine, intradialytic hypotensionDebates in NephrologyDebates in Nephrologyother202210.34067/KID.00074320212641-76502641-76502022-05-11T13:40:23-07:00Kidney360Debates in Nephrology10.34067/KID.0007432021This is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0007432021 and the COMMENTARY: 10.34067/KID.0007442021steven.brunelli@davita.com10.34067/KID.0007422021Wed, 11 May 2022 01:40:23 GMT-07:00Midodrine is an effective therapy for resistant intradialytic hypotension: CONThis is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0007432021 and the COMMENTARY: 10.34067/KID.0007442021Husarek, KathrynBrunelli, Steven M.2022-05-11T13:40:23-07:00doi:10.34067/KID.0007422021hwp:resource-id:kidney360;KID.0007422021v1American Society of NephrologyCopyright © 2022 American Society of NephrologyKidney360Midodrine, HypotensionDebates in NephrologyDebates in Nephrologyother202210.34067/KID.00074220212641-76502641-76502022-05-11T13:40:23-07:00Kidney360Debates in Nephrology10.34067/KID.000742202110.34067/KID.0004872021Fri, 10 Sep 2021 06:41:11 GMT-07:00Urine Sediment Exam Provides More Diagnostic Information in AKI than Novel Urinary Biomarkers: PROCavanaugh, Corey2021-09-10T06:41:11-07:00doi:10.34067/KID.0004872021hwp:resource-id:kidney360;3/4/597American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360glomerular and tubulointerstitial diseases, acute kidney injury, biomarker, casts, debate, hematuria, urine sediment examinationDebates in NephrologyDebates in Nephrologyresearch-article20222022-04-2810.34067/KID.00048720212641-76502021-09-10T06:41:11-07:002022-04-28Kidney360Debates in Nephrology3459759910.34067/KID.0004582021Fri, 10 Sep 2021 06:41:12 GMT-07:00Urine Sediment Exam Provides More Diagnostic Information in AKI than Novel Urinary Biomarkers: CONLa, AshleyKoyner, Jay L.2021-09-10T06:41:12-07:00doi:10.34067/KID.0004582021hwp:resource-id:kidney360;3/4/600American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360acute kidney injury and ICU nephrology, AKI, biomarkers, debate, dialysis, outcomes, urinalysisDebates in NephrologyDebates in Nephrologyresearch-article20222022-04-2810.34067/KID.00045820212641-76502021-09-10T06:41:12-07:002022-04-28Kidney360Debates in Nephrology3460060310.34067/KID.0005562021Fri, 10 Sep 2021 06:41:12 GMT-07:00Urine Sediment Exam Provides More Diagnostic Information in AKI than Novel Urinary Biomarkers: COMMENTARYUduman, JuniorYee, Jerry2021-09-10T06:41:12-07:00doi:10.34067/KID.0005562021hwp:resource-id:kidney360;3/4/604American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360acute kidney injury and ICU nephrology, acute kidney injury, biomarkers, debate, urine sedimentModerator CommentaryModerator Commentaryarticle-commentary20222022-04-2810.34067/KID.00055620212641-76502021-09-10T06:41:12-07:002022-04-28Kidney360Moderator Commentary34604607This is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the CON: 10.34067/KID.0007822021 and the COMMENTARY: 10.34067/KID.0002342022ghaffari@usc.edu10.34067/KID.0007782021Tue, 12 Apr 2022 01:16:11 GMT-07:00Peritoneal Dialysis Should Be Considered the First Option for Patients Requiring Urgent Start Dialysis: PROThis is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the CON: 10.34067/KID.0007822021 and the COMMENTARY: 10.34067/KID.0002342022Ghaffari, ArshiaDoria Medina Sanchez, Jorge2022-04-12T13:16:11-07:00doi:10.34067/KID.0007782021hwp:resource-id:kidney360;KID.0007782021v1American Society of NephrologyCopyright © 2022 American Society of NephrologyKidney360urgent dialysis, urgent-start peritoneal dialysis, Urgent-start PD, PD, Initial dialysis option, acute-start dialysis, acute-start PDDebates in NephrologyDebates in Nephrologyother202210.34067/KID.00077820212641-76502641-76502022-04-12T13:16:11-07:00Kidney360Debates in Nephrology10.34067/KID.0007782021This is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0007782021 and the CON: 10.34067/KID.0007822021mhr9r@virginia.edu10.34067/KID.0002342022Tue, 12 Apr 2022 01:16:11 GMT-07:00Peritoneal Dialysis Should Be Considered the First Option for Patients Requiring Urgent Start Dialysis: COMMENTARYThis is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0007782021 and the CON: 10.34067/KID.0007822021Rosner, Mitchell H.2022-04-12T13:16:11-07:00doi:10.34067/KID.0002342022hwp:resource-id:kidney360;KID.0002342022v1American Society of NephrologyCopyright © 2022 American Society of NephrologyKidney360Peritoneal DialysisModerator CommentaryModerator Commentaryother202210.34067/KID.00023420222641-76502641-76502022-04-12T13:16:11-07:00Kidney360Moderator Commentary10.34067/KID.0002342022This is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0007782021 and the COMMENTARY: 10.34067/KID.0002342022randy.luciano@yale.edu10.34067/KID.0007822021Tue, 12 Apr 2022 01:16:11 GMT-07:00Peritoneal Dialysis Should Be Considered the First Option for Patients Requiring Urgent Start Dialysis: CONThis is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0007782021 and the COMMENTARY: 10.34067/KID.0002342022Luciano, Randy L.2022-04-12T13:16:11-07:00doi:10.34067/KID.0007822021hwp:resource-id:kidney360;KID.0007822021v1American Society of NephrologyCopyright © 2022 American Society of NephrologyKidney360Peritoneal Dialysis, CKD, Urgent Start DialysisDebates in NephrologyDebates in Nephrologyother202210.34067/KID.00078220212641-76502641-76502022-04-12T13:16:11-07:00Kidney360Debates in Nephrology10.34067/KID.000782202110.34067/KID.0006632020Thu, 19 Aug 2021 01:30:39 GMT-07:00Extracorporeal Blood Purification Is Appropriate in Critically Ill Patients with COVID-19 and Multiorgan Failure: PROChung, Kevin K.Olson, Stephen W.2021-08-19T13:30:39-07:00doi:10.34067/KID.0006632020hwp:resource-id:kidney360;3/3/416American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360acute kidney injury and ICU nephrology, blood purification, COVID-19, cytokine storm, debates, extracorporeal, pathogen removal, sepsis, viremiaDebates in NephrologyDebates in Nephrologyresearch-article20222022-03-3110.34067/KID.00066320202641-76502021-08-19T13:30:39-07:002022-03-31Kidney360Debates in Nephrology3341641810.34067/KID.0007382020Thu, 19 Aug 2021 01:30:39 GMT-07:00Extracorporeal Blood Purification Is Appropriate in Critically Ill Patients with COVID-19 and Multiorgan Failure: CONKashani, KianoushForni, Lui G.2021-08-19T13:30:39-07:00doi:10.34067/KID.0007382020hwp:resource-id:kidney360;3/3/419American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360clinical nephrology, COVID-19, cytokine storm, debates, extracorporeal purificationDebates in NephrologyDebates in Nephrologyresearch-article20222022-03-3110.34067/KID.00073820202641-76502021-08-19T13:30:39-07:002022-03-31Kidney360Debates in Nephrology3341942210.34067/KID.0005242021Thu, 19 Aug 2021 01:30:39 GMT-07:00Extracorporeal Blood Purification Is Appropriate in Critically Ill Patients with COVID-19 and Multiorgan Failure: COMMENTARYOstermann, MarliesKoyner, Jay L.2021-08-19T13:30:39-07:00doi:10.34067/KID.0005242021hwp:resource-id:kidney360;3/3/423American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360acute kidney injury and ICU nephrology, blood purification, COVID-19, debatesModerator CommentaryModerator Commentaryarticle-commentary20222022-03-3110.34067/KID.00052420212641-76502021-08-19T13:30:39-07:002022-03-31Kidney360Moderator Commentary33423425This is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0000622022 and the CON: 10.34067/KID.0000092022atolwani@uabmc.edu10.34067/KID.0002002022Fri, 25 Mar 2022 01:37:16 GMT-07:00Nephrologists rather than intensivists should manage kidney replacement therapy in the ICU: COMMENTARYThis is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0000622022 and the CON: 10.34067/KID.0000092022Neyra, Javier A.Tolwani, Ashita2022-03-25T13:37:16-07:00doi:10.34067/KID.0002002022hwp:resource-id:kidney360;KID.0002002022v2American Society of NephrologyCopyright © 2022 American Society of NephrologyKidney360Nephrologists, Intensive Care Units, Renal Replacement TherapyModerator CommentaryModerator Commentaryother202210.34067/KID.00020020222641-76502641-76502022-03-25T13:37:16-07:00Kidney360Moderator Commentary10.34067/KID.0002002022This is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0000622022 and the COMMENTARY: 10.34067/KID.0002002022bagshaw@ualberta.ca10.34067/KID.0000092022Fri, 25 Mar 2022 01:37:16 GMT-07:00Nephrologists rather than intensivists should manage kidney replacement therapy in the ICU: CONThis is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0000622022 and the COMMENTARY: 10.34067/KID.0002002022Bagshaw, Sean M.2022-03-25T13:37:16-07:00doi:10.34067/KID.0000092022hwp:resource-id:kidney360;KID.0000092022v1American Society of NephrologyCopyright © 2022 American Society of NephrologyKidney360Nephrologists, Intensive Care Units, Renal Replacement TherapyDebates in NephrologyDebates in Nephrologyother202210.34067/KID.00000920222641-76502641-76502022-03-25T13:37:16-07:00Kidney360Debates in Nephrology10.34067/KID.0000092022This is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the CON: 10.34067/KID.0000092022 and the COMMENTARY: 10.34067/KID.0002002022palevsky@pitt.edu10.34067/KID.0000622022Fri, 25 Mar 2022 01:37:16 GMT-07:00Nephrologists rather than intensivists should manage kidney replacement therapy in the ICU: PROThis is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the CON: 10.34067/KID.0000092022 and the COMMENTARY: 10.34067/KID.0002002022Palevsky, Paul M.Wald, Ron2022-03-25T13:37:16-07:00doi:10.34067/KID.0000622022hwp:resource-id:kidney360;KID.0000622022v1American Society of NephrologyCopyright © 2022 American Society of NephrologyKidney360critical care nephrology, acute kidney injury, continuous kidney replacement therapy, hemodialysis, dialysis, critical care, Nephrologists, Intensive Care UnitsDebates in NephrologyDebates in Nephrologyother202210.34067/KID.00006220222641-76502641-76502022-03-25T13:37:16-07:00Kidney360Debates in Nephrology10.34067/KID.0000622022This is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the CON: 10.34067/KID.0007162021 and the COMMENTARY: 10.34067/KID.0001692022Adnan.Sharif@uhb.nhs.uk10.34067/KID.0007592020Tue, 08 Mar 2022 01:04:13 GMT-08:00Routine cardiac stress testing in kidney transplant candidates is only appropriate in symptomatic individuals: PROThis is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the CON: 10.34067/KID.0007162021 and the COMMENTARY: 10.34067/KID.0001692022Sharif, Adnan2022-03-08T13:04:13-08:00doi:10.34067/KID.0007592020hwp:resource-id:kidney360;KID.0007592020v1American Society of NephrologyCopyright © 2022 American Society of NephrologyKidney360Cardiac, Screening, Kidney transplant, Assessment, Mortality, Cardiovascular disease, RevascularizationDebates in NephrologyDebates in Nephrologyother202210.34067/KID.00075920202641-76502641-76502022-03-08T13:04:13-08:00Kidney360Debates in Nephrology3312122008200810.34067/KID.000759202020122012This is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0007592020 and the COMMENTARY: 10.34067/KID.0001692022jiun-ruey.hu@yale.edu10.34067/KID.0007162021Tue, 08 Mar 2022 01:04:13 GMT-08:00Routine cardiac stress testing in kidney transplant candidates is only appropriate in symptomatic individuals: CONThis is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0007592020 and the COMMENTARY: 10.34067/KID.0001692022Hu, Jiun-RueySugeng, Lissa2022-03-08T13:04:13-08:00doi:10.34067/KID.0007162021hwp:resource-id:kidney360;KID.0007162021v1American Society of NephrologyCopyright © 2022 American Society of NephrologyKidney360cardiology, stress testing, transplant candidates, risk stratification, angina, symptomsDebates in NephrologyDebates in Nephrologyother202210.34067/KID.00071620212641-76502641-76502022-03-08T13:04:13-08:00Kidney360Debates in Nephrology3312122013201310.34067/KID.000716202120162016This is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0007592020 and the CON: 10.34067/KID.0007162021hart1044@umn.edu10.34067/KID.0001692022Tue, 08 Mar 2022 01:04:13 GMT-08:00Routine cardiac stress testing in kidney transplant candidates is only appropriate in symptomatic individuals: COMMENTARYThis is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0007592020 and the CON: 10.34067/KID.0007162021Hart, AllysonWang, Jeffrey H.2022-03-08T13:04:13-08:00doi:10.34067/KID.0001692022hwp:resource-id:kidney360;KID.0001692022v1American Society of NephrologyCopyright © 2022 American Society of NephrologyKidney360cardiac screening, Kidney TransplantationModerator CommentaryModerator Commentaryother202210.34067/KID.00016920222641-76502641-76502022-03-08T13:04:13-08:00Kidney360Moderator Commentary3312122017201710.34067/KID.00016920222018201810.34067/KID.0007152020Fri, 06 Aug 2021 01:32:05 GMT-07:00Proactive High-Dose IV Iron Is Preferred Therapy in ESKD Patients: CONKshirsagar, Abhijit V.Li, Xiaojuan2021-08-06T13:32:05-07:00doi:10.34067/KID.0007152020hwp:resource-id:kidney360;3/2/211American Society of NephrologyCopyright © 2021 by the American Society of NephrologyKidney360dialysis, chronic kidney disease, debate, hemodialysis, ironDebates in NephrologyDebates in Nephrologyresearch-article20212022-02-2410.34067/KID.00071520202641-76502021-08-06T13:32:05-07:002022-02-24Kidney360Debates in Nephrology3221121310.34067/KID.0004892021Fri, 06 Aug 2021 01:32:05 GMT-07:00Proactive High-Dose IV Iron Is Preferred Therapy in ESKD Patients: COMMENTARYLiu, Frank2021-08-06T13:32:05-07:00doi:10.34067/KID.0004892021hwp:resource-id:kidney360;3/2/214American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360dialysis, anemia, chronic kidney disease, debate, ironModerator CommentaryModerator Commentaryarticle-commentary20222022-02-2410.34067/KID.00048920212641-76502021-08-06T13:32:05-07:002022-02-24Kidney360Moderator Commentary3221421610.34067/KID.0002442021Fri, 06 Aug 2021 01:32:05 GMT-07:00Proactive High-Dose IV Iron Is Preferred Therapy in ESKD Patients: PROCoyne, Daniel W.2021-08-06T13:32:05-07:00doi:10.34067/KID.0002442021hwp:resource-id:kidney360;3/2/208American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360dialysis, debate, ferryl iron, hemodialysis, iron, mortalityDebates in NephrologyDebates in Nephrologyresearch-article20222022-02-2410.34067/KID.00024420212641-76502021-08-06T13:32:05-07:002022-02-24Kidney360Debates in Nephrology3220821010.34067/KID.0006512020Tue, 04 May 2021 02:13:17 GMT-07:00Bile Acids Are Important Contributors to AKI Associated with Liver Disease: CONAllegretti, Andrew S.Belcher, Justin M.2021-05-04T14:13:17-07:00doi:10.34067/KID.0006512020hwp:resource-id:kidney360;3/1/21American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360acute kidney injury and ICU nephrology, AKI, bile cast nephropathy, cholemic nephropathy, cirrhosisDebates in NephrologyDebates in Nephrologyresearch-article20222022-01-2710.34067/KID.00065120202641-76502021-05-04T14:13:17-07:002022-01-27Kidney360Debates in Nephrology31212410.34067/KID.0005932020Tue, 04 May 2021 02:13:17 GMT-07:00Bile Acids Are Important Contributors to AKI Associated with Liver Disease: PROFickert, PeterRosenkranz, Alexander R.2021-05-04T14:13:17-07:00doi:10.34067/KID.0005932020hwp:resource-id:kidney360;3/1/17American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360acute kidney injury and ICU nephrology, acute kidney injury, bile acids, hepatorenal syndrome, liver failureDebates in NephrologyDebates in Nephrologyresearch-article20222022-01-2710.34067/KID.00059320202641-76502021-05-04T14:13:17-07:002022-01-27Kidney360Debates in Nephrology31172010.34067/KID.0002422021Tue, 04 May 2021 02:13:17 GMT-07:00Bile Acids are Important Contributors of AKI Associated with Liver Disease: COMMENTARYLopez-Ruiz, ArnaldoJuncos, Luis A.2021-05-04T14:13:17-07:00doi:10.34067/KID.0002422021hwp:resource-id:kidney360;3/1/25American Society of NephrologyCopyright © 2022 by the American Society of NephrologyKidney360acute kidney injury and ICU nephrology, AKI, bile acids, cirrhosis, debates in nephrology, hepatorenal syndrome, liver diseaseModerator CommentaryModerator Commentaryresearch-article20222022-01-2710.34067/KID.00024220212641-76502021-05-04T14:13:17-07:002022-01-27Kidney360Moderator Commentary31252710.34067/KID.0002492021Mon, 19 Apr 2021 09:28:55 GMT-07:00Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: COMMENTARYKlomjit, NattawatZand, Ladan2021-04-19T09:28:55-07:00doi:10.34067/KID.0002492021hwp:resource-id:kidney360;2/11/1702American Society of NephrologyCopyright © 2021 by the American Society of NephrologyKidney360glomerular and tubulointerstitial diseases, cyclophosphamide, glomerulonephritis, membranous, membranous nephropathy, MN, Ponticelli regimen, rituximabModerator CommentaryModerator Commentaryresearch-article20212021-11-2510.34067/KID.00024920212641-76502021-04-19T09:28:55-07:002021-11-25Kidney360Moderator Commentary2111702170510.34067/KID.0001842021Mon, 19 Apr 2021 09:28:55 GMT-07:00Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: PROOliva-Damaso, NestorBomback, Andrew S.2021-04-19T09:28:55-07:00doi:10.34067/KID.0001842021hwp:resource-id:kidney360;2/11/1696American Society of NephrologyCopyright © 2021 by the American Society of NephrologyKidney360glomerular and tubulointerstitial diseases, cyclophosphamide, immunosuppressive agents, membranous glomerulonephritis, rituximabDebates in NephrologyDebates in Nephrologyresearch-article20212021-11-2510.34067/KID.00018420212641-76502021-04-19T09:28:55-07:002021-11-25Kidney360Debates in Nephrology2111696169810.34067/KID.0001432021Mon, 19 Apr 2021 09:28:55 GMT-07:00Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: CONvan de Logt, Anne-ElsWetzels, Jack F.2021-04-19T09:28:55-07:00doi:10.34067/KID.0001432021hwp:resource-id:kidney360;2/11/1699American Society of NephrologyCopyright © 2021 by the American Society of NephrologyKidney360glomerular and tubulointerstitial diseases, cyclophosphamide, membranous, membranous glomerulonephritis, nephrotic syndrome, rituximabDebates in NephrologyGlomerular and Tubulointerstitial DiseasesDebates in NephrologyGlomerular and Tubulointerstitial Diseasesresearch-article20212021-11-2510.34067/KID.00014320212641-76502021-04-19T09:28:55-07:002021-11-25Kidney360Debates in Nephrology2111699170110.34067/KID.0000022021Fri, 09 Apr 2021 09:22:47 GMT-07:00Should Oral Anticoagulation Be Used in ESKD Patients on Hemodialysis with Atrial Fibrillation?: PRODevabhaktuni, Subodh R.Mounsey, J. Paul2021-04-09T09:22:47-07:00doi:10.34067/KID.0000022021hwp:resource-id:kidney360;2/9/1405American Society of NephrologyCopyright © 2021 by the American Society of NephrologyKidney360clinical nephrology, apixaban, coumadin, ESKD, ESRD, OACDebates in NephrologyDebates in Nephrologyresearch-article20212021-09-3010.34067/KID.00000220212641-76502021-04-09T09:22:47-07:002021-09-30Kidney360Debates in Nephrology291405140810.34067/KID.0001372021Fri, 09 Apr 2021 09:22:47 GMT-07:00Should Oral Anticoagulation Be Used in ESKD Patients on Hemodialysis with Atrial Fibrillation?: COMMENTARYMavrakanas, Thomas A.2021-04-09T09:22:47-07:00doi:10.34067/KID.0001372021hwp:resource-id:kidney360;2/9/1412American Society of NephrologyCopyright © 2021 by the American Society of NephrologyKidney360dialysis, anticoagulation, apixaban, atrial fibrillation, bleeding, hemodialysis, rivaroxaban, stroke, warfarinModerator CommentaryModerator Commentaryarticle-commentary20212021-09-3010.34067/KID.00013720212641-76502021-04-09T09:22:47-07:002021-09-30Kidney360Moderator Commentary291412141410.34067/KID.0006602020Fri, 09 Apr 2021 09:22:47 GMT-07:00Should Oral Anticoagulation Be Used in ESKD Patients on Hemodialysis with Atrial Fibrillation?: CONLidgard, BenjaminBansal, Nisha2021-04-09T09:22:47-07:00doi:10.34067/KID.0006602020hwp:resource-id:kidney360;2/9/1409American Society of NephrologyCopyright © 2021 by the American Society of NephrologyKidney360dialysis, anticoagulants, atrial fibrillation, blood coagulation, ESKD, hemodialysisDebates in NephrologyDebates in Nephrologyresearch-article20212021-09-3010.34067/KID.00066020202641-76502021-04-09T09:22:47-07:002021-09-30Kidney360Debates in Nephrology291409141110.34067/KID.0006832020Fri, 05 Feb 2021 01:36:13 GMT-08:00Corticosteroids Should Be Used to Treat Slowly Progressive IgA Nephropathy: COMMENTARYCampbell, Kirk N.2021-02-05T13:36:13-08:00doi:10.34067/KID.0006832020hwp:resource-id:kidney360;2/7/1084American Society of NephrologyCopyright © 2021 by the American Society of NephrologyKidney360clinical nephrology, adrenal cortex hormones, debates in nephrology, IgA, IGA glomerulonephritis, steroidsModerator CommentaryModerator Commentaryresearch-article20212021-07-2910.34067/KID.00068320202641-76502021-02-05T13:36:13-08:002021-07-29Kidney360Moderator Commentary271084108610.34067/KID.0007192020Fri, 05 Feb 2021 03:31:07 GMT-08:00Corticosteroids Should Be Used To Treat Slowly Progressive IgA Nephropathy: PROCunningham, Amanda M.Reich, Heather N.2021-02-05T15:31:07-08:00doi:10.34067/KID.0007192020hwp:resource-id:kidney360;2/7/1078American Society of NephrologyCopyright © 2021 by the American Society of NephrologyKidney360glomerular and tubulointerstitial diseases, adrenal cortex hormones, corticosteroids, glomerulonephritis, IGA glomerulonephritis, IgA nephropathy, therapy, treatmentDebates in NephrologyDebates in Nephrologyresearch-article20212021-07-2910.34067/KID.00071920202641-76502021-02-05T15:31:07-08:002021-07-29Kidney360Debates in Nephrology271078108010.34067/KID.0007672020Fri, 05 Feb 2021 02:06:35 GMT-08:00Corticosteroids Should Be Used to Treat Slowly Progressive IgA Nephropathy: CONBarratt, Jonathan2021-02-05T14:06:35-08:00doi:10.34067/KID.0007672020hwp:resource-id:kidney360;2/7/1081American Society of NephrologyCopyright © 2021 by the American Society of NephrologyKidney360glomerular and tubulointerstitial diseases, adrenal cortex hormones, IgA glomerulonephritis, IgA nephropathy, steroidsDebates in NephrologyDebates in Nephrologyresearch-article20212021-07-2910.34067/KID.00076720202641-76502021-02-05T14:06:35-08:002021-07-29Kidney360Debates in Nephrology271081108310.34067/KID.0004102020Thu, 14 Jan 2021 06:25:51 GMT-08:00Should PLEX Be Used for Severe AKI and/or Pulmonary Hemorrhage in ANCA-Associated Vasculitis (AAV)? CONGlassock, Richard J.2021-01-14T06:25:51-08:00doi:10.34067/KID.0004102020hwp:resource-id:kidney360;2/5/779American Society of NephrologyCopyright © 2021 by the American Society of NephrologyKidney360clinical nephrology, ANCA vasculitis, diffuse alveolar hemorrhage, plasmapheresis, PLEXDebates in NephrologyDebates in Nephrologyresearch-article20212021-05-2710.34067/KID.00041020202641-76502021-01-14T06:25:51-08:002021-05-27Kidney360Debates in Nephrology2577978110.34067/KID.0006762020Thu, 14 Jan 2021 06:25:51 GMT-08:00Should PLEX Be Used for Severe AKI and/or Pulmonary Hemorrhage in ANCA-Associated Vasculitis (AAV)? PRODerebail, Vimal K.2021-01-14T06:25:51-08:00doi:10.34067/KID.0006762020hwp:resource-id:kidney360;2/5/776American Society of NephrologyCopyright © 2021 by the American Society of NephrologyKidney360glomerular and tubulointerstitial diseases, ANCA, plasma exchange, PLEX, vasculitisDebates in NephrologyDebates in Nephrologyresearch-article20212021-05-2710.34067/KID.00067620202641-76502021-01-14T06:25:51-08:002021-05-27Kidney360Debates in Nephrology2577677810.34067/KID.0000072021Thu, 14 Jan 2021 06:25:51 GMT-08:00Should PLEX Be Used for Severe AKI and/or Pulmonary Hemorrhage in ANCA-Associated Vasculitis (AAV)? COMMENTARYFalk, Ronald J.2021-01-14T06:25:51-08:00doi:10.34067/KID.0000072021hwp:resource-id:kidney360;2/5/782American Society of NephrologyCopyright © 2021 by the American Society of NephrologyKidney360acute kidney injury and ICU nephrology, acute kidney injury, ANCA-associated vasculitis, PLEX, pulmonary hemorrhageModerator CommentaryModerator Commentaryresearch-article20212021-05-2710.34067/KID.00000720212641-76502021-01-14T06:25:51-08:002021-05-27Kidney360Moderator Commentary2578278310.34067/KID.0006862020Wed, 16 Dec 2020 11:33:50 GMT-08:00Patients with Hepatorenal Syndrome Should Be Dialyzed? COMMENTARYRegner, Kevin R.2020-12-16T11:33:50-08:00doi:10.34067/KID.0006862020hwp:resource-id:kidney360;2/3/413American Society of NephrologyCopyright © 2021 by the American Society of NephrologyKidney360acute kidney injury and ICU nephrology, cirrhosis, hepatorenal syndrome, hyperammonemia, renal replacement therapyModerator CommentaryModerator Commentaryarticle-commentary20212021-03-2510.34067/KID.00068620202641-76502020-12-16T11:33:50-08:002021-03-25Kidney360Moderator Commentary2341341410.34067/KID.0006952020Wed, 16 Dec 2020 11:33:50 GMT-08:00Patients with Hepatorenal Syndrome Should Be Dialyzed? PROVelez, Juan Carlos Q.2020-12-16T11:33:50-08:00doi:10.34067/KID.0006952020hwp:resource-id:kidney360;2/3/406American Society of NephrologyCopyright © 2021 by the American Society of NephrologyKidney360acute kidney injury and ICU nephrology, AKI, cirrhosis, CRRT, decompensated, dialysis, end-of-life, futility, HRS-1, palliative, RRTDebates in NephrologyDebates in Nephrologyresearch-article20212021-03-2510.34067/KID.00069520202641-76502020-12-16T11:33:50-08:002021-03-25Kidney360Debates in Nephrology2340640910.34067/KID.0006872020Wed, 16 Dec 2020 11:33:50 GMT-08:00Patients with Hepatorenal Syndrome Should Be Dialyzed? CONWadei, Hani M.2020-12-16T11:33:50-08:00doi:10.34067/KID.0006872020hwp:resource-id:kidney360;2/3/410American Society of NephrologyCopyright © 2021 by the American Society of NephrologyKidney360acute kidney injury and ICU nephrology, dialysis, hepatorenal syndrome, liver cirrhosis, renal replacement therapyDebates in NephrologyDebates in Nephrologyresearch-article20212021-03-2510.34067/KID.00068720202641-76502020-12-16T11:33:50-08:002021-03-25Kidney360Debates in Nephrology2341041210.34067/KID.0005572020Thu, 03 Dec 2020 06:20:01 GMT-08:00Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: CONPun, Patrick H.Crowley, Susan T.2020-12-03T06:20:01-08:00doi:10.34067/KID.0005572020hwp:resource-id:kidney360;2/1/13American Society of NephrologyCopyright © 2021 by the American Society of NephrologyKidney360chronic kidney disease, Gadolinium, nephrogenic systemic fibrosis, safetyDebates in NephrologyDebates in Nephrologyresearch-article20212021-01-2810.34067/KID.00055720202641-76502020-12-03T06:20:01-08:002021-01-28Kidney360Debates in Nephrology21131510.34067/KID.0005792020Thu, 03 Dec 2020 06:20:01 GMT-08:00Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: PRORodby, Roger A.2020-12-03T06:20:01-08:00doi:10.34067/KID.0005792020hwp:resource-id:kidney360;2/1/10American Society of NephrologyCopyright © 2021 by the American Society of NephrologyKidney360chronic kidney disease, CKD 4/5, gadolinium, nephrogenic systemic fibrosisDebates in NephrologyDebates in Nephrologyresearch-article20212021-01-2810.34067/KID.00057920202641-76502020-12-03T06:20:01-08:002021-01-28Kidney360Debates in Nephrology21101210.34067/KID.0006002020Thu, 03 Dec 2020 06:20:01 GMT-08:00Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: COMMENTARYAbu-Alfa, Ali K.2020-12-03T06:20:01-08:00doi:10.34067/KID.0006002020hwp:resource-id:kidney360;2/1/16American Society of NephrologyCopyright © 2021 by the American Society of NephrologyKidney360chronic kidney disease, gadolinium, magnetic resonance imaging, nephrogenic systemic fibrosisModerator CommentaryModerator Commentaryarticle-commentary20212021-01-2810.34067/KID.00060020202641-76502020-12-03T06:20:01-08:002021-01-28Kidney360Moderator Commentary21161910.34067/KID.0005112020Wed, 23 Sep 2020 01:37:51 GMT-07:00Can NSAIDs Be Used Safely for Analgesia in Patients with CKD?: CONGuthrie, Bruce2020-09-23T13:37:51-07:00doi:10.34067/KID.0005112020hwp:resource-id:kidney360;1/11/1189American Society of NephrologyCopyright © 2020 by the American Society of NephrologyKidney360clinical nephrology, analgesia, chronic renal insufficiency, hypesthesia, non-steroidal anti-inflammatory agents, pain managementDebates in NephrologyDebates in Nephrologyresearch-article20202020-11-2510.34067/KID.00051120202641-76502020-09-23T13:37:51-07:002020-11-25Kidney360Debates in Nephrology1111189119110.34067/KID.0004652020Wed, 23 Sep 2020 01:37:51 GMT-07:00Can NSAIDs Be Used Safely for Analgesia in Patients with CKD?: COMMENTARYBaker, Megan L.Perazella, Mark A.2020-09-23T13:37:51-07:00doi:10.34067/KID.0004652020hwp:resource-id:kidney360;1/11/1192American Society of NephrologyCopyright © 2020 by the American Society of NephrologyKidney360clinical nephrology, acute kidney injury, analgesia, chronic kidney disease, chronic renal insufficiency, hyperkalemia, hypesthesia, nephrotoxicity, non-steroidal anti-inflammatory drugs, pain managementModerator CommentaryModerator Commentaryarticle-commentary20202020-11-2510.34067/KID.00046520202641-76502020-09-23T13:37:51-07:002020-11-25Kidney360Moderator Commentary1111192119410.34067/KID.0004582020Wed, 23 Sep 2020 01:37:51 GMT-07:00Can NSAIDs Be Used Safely for Analgesia in Patients with CKD?: PROBarreto, Erin F.Feely, Molly A.2020-09-23T13:37:51-07:00doi:10.34067/KID.0004582020hwp:resource-id:kidney360;1/11/1184American Society of NephrologyCopyright © 2020 by the American Society of NephrologyKidney360nephro-pharmacology, acute kidney injury, analgesia, nephrotoxicity, NSAID, opioids, pharmacodynamic, pharmacokineticDebates in NephrologyDebates in Nephrologyresearch-article20202020-11-2510.34067/KID.00045820202641-76502020-09-23T13:37:51-07:002020-11-25Kidney360Debates in Nephrology1111184118810.34067/KID.0003262020Mon, 13 Jul 2020 01:27:35 GMT-07:00Kidney Biopsy Is Required for Nephrotic Syndrome with PLA2R+ and Normal Kidney Function: The Con ViewBobart, Shane A.Fervenza, Fernando C.2020-07-13T13:27:35-07:00doi:10.34067/KID.0003262020hwp:resource-id:kidney360;1/9/890American Society of NephrologyCopyright © 2020 by the American Society of NephrologyKidney360clinical nephrology, biopsy, glomerulonephritis, membranous, membranous nephropathy, nephrotic syndrome, PLA2R1 protein, human, receptors, PhospholipaseA2Debates in NephrologyDebates in Nephrologyresearch-article20202020-09-2410.34067/KID.00032620202641-76502020-07-13T13:27:35-07:002020-09-24Kidney360Debates in Nephrology1989089310.34067/KID.0003752020Mon, 13 Jul 2020 01:27:35 GMT-07:00Kidney Biopsy Is Required for Nephrotic Syndrome with PLA2R+ and Normal Kidney Function: ProHogan, Jonathan J.2020-07-13T13:27:35-07:00doi:10.34067/KID.0003752020hwp:resource-id:kidney360;1/9/887American Society of NephrologyCopyright © 2020 by the American Society of NephrologyKidney360glomerular and tubulointerstitial diseases, glomerulonephritis, membranous, kidney biopsy, membranous nephropathy, PLA2R1 protein, humanDebates in NephrologyDebates in Nephrologyresearch-article20202020-09-2410.34067/KID.00037520202641-76502020-07-13T13:27:35-07:002020-09-24Kidney360Debates in Nephrology1988788910.34067/KID.0004012020Mon, 13 Jul 2020 01:27:35 GMT-07:00Kidney Biopsy Is Required for Nephrotic Syndrome with PLA2R+ and Normal Kidney Function: CommentaryGlassock, Richard J.2020-07-13T13:27:35-07:00doi:10.34067/KID.0004012020hwp:resource-id:kidney360;1/9/894American Society of NephrologyCopyright © 2020 by the American Society of NephrologyKidney360clinical nephrology, glomerulonephritis, kidney biopsy, membranous nephropathy, PLA2R antibody, PLA2R1 protein, humanModerator CommentaryModerator Commentaryarticle-commentary20202020-09-2410.34067/KID.00040120202641-76502020-07-13T13:27:35-07:002020-09-24Kidney360Moderator Commentary1989489610.34067/KID.0003172020Wed, 17 Jun 2020 01:34:06 GMT-07:00Is an Environmental Nephrotoxin the Primary Cause of CKDu (Mesoamerican Nephropathy)? PRODe Broe, Marc E.Vervaet, Bejamin A.2020-06-17T13:34:06-07:00doi:10.34067/KID.0003172020hwp:resource-id:kidney360;1/7/591American Society of NephrologyCopyright © 2020 by the American Society of NephrologyKidney360chronic kidney disease, agriculture, agrochemicals, atrophy, calcineurin inhibition, Central America, CKDu, lysosome, Mesoamerican nephropathy, nephritis, interstitial, nephrotoxicity, pesticide, proximal tubule, renal insufficiency, chronic, Sri Lanka, toxinDebates in NephrologyDebates in Nephrologyresearch-article20202020-07-3010.34067/KID.00031720202641-76502020-06-17T13:34:06-07:002020-07-30Kidney360Debates in Nephrology1759159510.34067/KID.0002922020Wed, 17 Jun 2020 01:34:06 GMT-07:00Is an Environmental Nephrotoxin the Primary Cause of CKDu (Mesoamerican Nephropathy)? CONWesseling, Catharina2020-06-17T13:34:06-07:00doi:10.34067/KID.0002922020hwp:resource-id:kidney360;1/7/596American Society of NephrologyCopyright © 2020 by the American Society of NephrologyKidney360chronic kidney disease, CKDnt, CKDu, etiology, heat stress, India, Mesoamerican nephropathy, metals, occupation, pesticides, Sri LankaDebates in NephrologyDebates in Nephrologyresearch-article20202020-07-3010.34067/KID.00029220202641-76502020-06-17T13:34:06-07:002020-07-30Kidney360Debates in Nephrology1759660110.34067/KID.0003412020Wed, 17 Jun 2020 01:34:06 GMT-07:00Is an Environmental Nephrotoxin the Primary Cause of CKDu (Mesoamerican Nephropathy)? CommentaryMadero, Magdalena2020-06-17T13:34:06-07:00doi:10.34067/KID.0003412020hwp:resource-id:kidney360;1/7/602American Society of NephrologyCopyright © 2020 by the American Society of NephrologyKidney360chronic kidney disease, CKDu, environmental toxins, Mesoamerican NephropathyModerator CommentaryModerator Commentaryarticle-commentary20202020-07-3010.34067/KID.00034120202641-76502020-06-17T13:34:06-07:002020-07-30Kidney360Moderator Commentary1760260310.34067/KID.0001192019Tue, 11 Feb 2020 01:38:00 GMT-08:00Kidney Biopsy Should Be Performed to Document the Cause of Immune Checkpoint Inhibitor–Associated Acute Kidney Injury: PROEijgelsheim, MarkSprangers, Ben2020-02-11T13:38:00-08:00doi:10.34067/KID.0001192019hwp:resource-id:kidney360;1/3/158American Society of NephrologyCopyright © 2020 by the American Society of NephrologyKidney360Clinical Nephrology, Glomerular and Tubulointerstitial Diseases, checkpoint inhibitors, interstitial nephritis, kidney biopsy, onconephrologyDebates in NephrologyDebates in Nephrologyresearch-article20202020-03-2610.34067/KID.00011920192641-76502020-02-11T13:38:00-08:002020-03-26Kidney360Debates in Nephrology1315816110.34067/KID.0000132020Tue, 11 Feb 2020 01:38:00 GMT-08:00Kidney Biopsy Should Be Performed to Document the Cause of Immune Checkpoint Inhibitor–Associated Acute Kidney Injury: CONGutgarts, VictoriaGlezerman, Ilya G.2020-02-11T13:38:00-08:00doi:10.34067/KID.0000132020hwp:resource-id:kidney360;1/3/162American Society of NephrologyCopyright © 2020 by the American Society of NephrologyKidney360Acute Kidney Injury and ICU Nephrology, Abatacept, Apoptosis Regulatory Proteins, Immune checkpoint inhibitors, Immune System, Neoplasms, Programmed Cell Death 1 ReceptorDebates in NephrologyDebates in Nephrologyresearch-article20202020-03-2610.34067/KID.00001320202641-76502020-02-11T13:38:00-08:002020-03-26Kidney360Debates in Nephrology1316216510.34067/KID.0001072019Tue, 11 Feb 2020 01:38:00 GMT-08:00Kidney Biopsy Should Be Performed to Document the Cause of Immune Checkpoint Inhibitor–Associated Acute Kidney Injury: CommentaryPerazella, Mark A.2020-02-11T13:38:00-08:00doi:10.34067/KID.0001072019hwp:resource-id:kidney360;1/3/166American Society of NephrologyCopyright © 2020 by the American Society of NephrologyKidney360Acute Kidney Injury and ICU Nephrology, Clinical Nephrology, acute kidney injury, acute tubular injuury, acute tubulinterstitial nephritis, cancer, eosinophilia, immune checkpoint inhibitor, kidney biopsy, pyuria, T-cells, urinalysisModerator CommentaryModerator Commentaryarticle-commentary20202020-03-2610.34067/KID.00010720192641-76502020-02-11T13:38:00-08:002020-03-26Kidney360Moderator Commentary1316616810.34067/KID.0000702020Tue, 14 Apr 2020 05:30:10 GMT-07:00Should Buttonhole Cannulation of Arteriovenous Fistulas be Used? PROLabriola, Laura2020-04-14T05:30:10-07:00doi:10.34067/KID.0000702020hwp:resource-id:kidney360;1/5/318American Society of NephrologyCopyright © 2020 by the American Society of NephrologyKidney360dialysis, arteriovenous fistulas, buttonhole cannulation, catheterization, disinfection, needles, punctures, renal dialysisDebates in NephrologyDebates in Nephrologyresearch-article20202020-05-2810.34067/KID.00007020202641-76502020-04-14T05:30:10-07:002020-05-28Kidney360Debates in Nephrology1531832110.34067/KID.0001682020Tue, 14 Apr 2020 05:30:10 GMT-07:00Should Buttonhole Cannulation of Arteriovenous Fistulas Be Used? Moderator CommentaryAgarwal, Anil K.2020-04-14T05:30:10-07:00doi:10.34067/KID.0001682020hwp:resource-id:kidney360;1/5/326American Society of NephrologyCopyright © 2020 by the American Society of NephrologyKidney360Dialysis, Buttonhole, Cannulation, Hemodialysis vascular access, Home hemodialysis, Infections, Rope LadderModerator CommentaryModerator Commentaryarticle-commentary20202020-05-2810.34067/KID.00016820202641-76502020-04-14T05:30:10-07:002020-05-28Kidney360Moderator Commentary1532632910.34067/KID.0000602019Tue, 14 Apr 2020 05:30:10 GMT-07:00Should Buttonhole Cannulation of Arteriovenous Fistulas Be Used? CONMacRae, Jennifer M.2020-04-14T05:30:10-07:00doi:10.34067/KID.0000602019hwp:resource-id:kidney360;1/5/322American Society of NephrologyCopyright © 2020 by the American Society of NephrologyKidney360Dialysis, arteriovenous fistula, buttonhole, constant site cannulation, fistula, hemodialysis, rope ladder cannulation, vascular accessDebates in NephrologyDebates in Nephrologyresearch-article20202020-05-2810.34067/KID.00006020192641-76502020-04-14T05:30:10-07:002020-05-28Kidney360Debates in Nephrology1532232510.34067/KID.0000742019Thu, 02 Jan 2020 12:00:00 GMT-08:00Is There a Role for Device Therapies in Resistant Hypertension?Peixoto, Aldo J.2020-01-02T00:00:00-08:00doi:10.34067/KID.0000742019hwp:resource-id:kidney360;1/1/9American Society of NephrologyCopyright © 2020 by the American Society of NephrologyKidney360Clinical Nephrology, Hypertension, Baroreflex activation therapy, Blood Pressure, renal denervation, Resistant HypertensionDebates in NephrologyDebates in Nephrologyresearch-article20202020-01-3010.34067/KID.00007420192641-76502020-01-02T00:00:00-08:002020-01-30Kidney360Debates in Nephrology1191310.34067/KID.0000682019Thu, 02 Jan 2020 12:00:00 GMT-08:00Is There Any Role for Device Therapies in Resistant Hypertension? CommentaryChang, Tara I.2020-01-02T00:00:00-08:00doi:10.34067/KID.0000682019hwp:resource-id:kidney360;1/1/14American Society of NephrologyCopyright © 2020 by the American Society of NephrologyKidney360Hypertension, blood pressure, Resistant hypertensionModerator CommentaryModerator Commentaryarticle-commentary20202020-01-3010.34067/KID.00006820192641-76502020-01-02T00:00:00-08:002020-01-30Kidney360Moderator Commentary11141510.34067/KID.0000582019Thu, 02 Jan 2020 05:30:08 GMT-08:00Is There Any Role for Device Therapies in Resistant Hypertension? PROTownsend, Raymond R.2020-01-02T05:30:08-08:00doi:10.34067/KID.0000582019hwp:resource-id:kidney360;1/1/6American Society of NephrologyCopyright © 2020 by the American Society of NephrologyKidney360Hypertension, Blood Pressure, renal denervation, Resistant HypertensionDebates in NephrologyDebates in Nephrologyother20202020-01-3010.34067/KID.00005820192641-76502020-01-02T05:30:08-08:002020-01-30Kidney360Debates in Nephrology1168